SUMMARY Ten annual cohorts of men suffering from their first myocardial infarction have been followed up to a maximum period of 10.5 years. One thousand and twenty-three male patients of 1306 were smokers. Three months after the infarction 55% had stopped smoking and 45% continued smoking. These two groups were then compared and followed with regard to non-fatal reinfarctions and deaths.
Cigarette smoking is one of the major risk factors for the development of coronary heart disease.' I-In a previous report we have shown the beneficial effects of stopping smoking after myocardial infarction. Those who stopped smoking had only half the cardiovascular mortality rate and only half the rate of non-fatal recurrences compared with those who continued to smoke. 4 An increased death rate among those who continue to smoke has also been shown by others.S- 7 The aim of the present study was to investigate whether our early findings were stable or even enhanced during a prolonged follow-up, and if the proposed effect of changing the smoking habit differed in certain age-groups.
Patients and methods
As from 1 January 1968, all cases of myocardial infarction occurring in Goteborg have been registered by the MI Register.8 The present study comprised men who suffered their first myocardial infarction and Accepted for publication 7 January 1983 416 whose ages were as follows: for the two years 1968 to 1969 all patients aged 55 years and below; for the two years 1970 to 1971 all patients aged 67 years and below (with the exception of a random 30% sample for those aged 57 to 59 who formed a reference group); for 1972 every other patient below 65 years; from 1973 up to and including 31 December 1977 all patients aged 59 years and below, making a total of 1306 male patients who survived their stay in hospital.
All patients were followed from discharge up to a maximum period of 10-5 years at a special postmyocardial infarction clinic. Control examinations took place immediately after discharge (one to three weeks), and three, 12 The reinfarction was considered non-fatal if the patient was discharged alive from hospital or survived reinfarction for more than 28 days. The diagnosis "death caused by coronary heart disease" was based in 800/o of the cases on necropsy and in 20% of the cases on typical course of the fatal episode. Death certificates and necropsy records were available for all patients who died. Deaths were divided into those caused by coronary heart disease and other deaths. In the present investigation other causes of death comprised stroke, pulmonary embolism, cancer, sepsis, and suicide."
The present report deals with the effect of stopping smoking by comparing those who smoked before myocardial infarction and later stopped, with those who continued to smoke after the infarction.
Statistical analyses
The Mantel-Haenszel test was used to get a crude test of the difference between the two survival curves. The Cox proportional hazard model was used.'2 13 This model assumes proportional hazards, that is the effect of stopping smoking should be proportional to the mortality rate (hazard). Early after the myocardial infarction there is an extremely high mortality rate but the effect of stopping smoking is probably low in this period. In this study the patients are included after three months. A plot of the different hazard functions showed that the Cox model was well suited for this observation period. The probability of cardiovascular death during the initial follow-up was calculated using multiple logistic models. ' There is no ideal model to adjust for prognostic factors. Therefore, two models were used. In model I age, peak enzyme level, and the occurrence of left ventricular failure were used in a Cox analysis. In model II Cox analysis included age and a logistic severity index'4 using previous hypertension and variables listed in Tables 1 and 2. For analyses of the fourfold The prognostic comparability of the two groups in the present study was assessed. Some preinfarction characteristics are presented in Table 5 . The fre- (Table 1 and 2) in respect of left ventricular failure and mean peak enzyme change. According to prognostic model I there was a 9-3% higher expected mortality after two years in the group that stopped smoking. According to prognostic model II this difference in expected mortality was slightly less, but still the group that stopped smoking was biased to a 8-1% higher expected mortality for two years of follow-up (p<001). This difference was small, however; the expected two year mortality for the group who continued to smoke was 8-3% and 9-00/o for those who stopped smoking.
Other variables after discharge from hospital have been studied. During the follow-up period there were no differences between the groups in the frequency of angina pectoris, diabetes, or hypertension. The blood pressure levels three, 12, and 24 months after infarction did not differ between the groups. The cholesterol and triglyceride values at the same controls were also comparable. Treatment with lipid lowering drugs was never more frequent than 8% in the highest cholesterol quintile and was the same in both groups. The mean weight tended to be higher one year after the myocardial infarction for those who stopped smoking (p=0084). The frequency of beta blocking treatment increased during the study period, but was comparable in the two groups.
There were altogether 223 deaths during up to 10-5 years of follow-up and these were related to smoking habits three months after myocardial infarction (Table 6 ). In the group who stopped smoking the cumulative survival rate was 84% after five years and in the group who continued to smoke the five year survival rate was 78% (Fig. 1) recurrences during up to 10 5 years follow-up ( Table  7) . The difference between the two groups was not strongly related to age above and below 50. The cumulative reinfarction rate after five years was 21% for those who stopped smoking and 30% for those who continued to smoke ( Fig. 4 ; p<O-OOOl).
Below 50 years of age, those who stopped smoking had a five year reinfarction rate of 20% and those who continued to smoke had a rate of 27% (p=0.06). Above 50 years of age those who stopped smoking had a reinfarction rate of 21% and those who continued a rate of 31% (p<0-01).
Discussion
The patients studied were unselected and the methods used were standardised and unchanged throughout the period of follow-up.8 9 The number of patients who could not be followed up was negligible. The two groups studied were previously shown to have had an equal tobacco consumption before the onset of myocardial infarction. 4 Patients who stopped smoking after infarction seldom resumed smoking.-5 This was in contrast to experience of antismoking campaigns in the general population.'6 The validity of the reported tobacco consumption after myocardial infarction was tested in a separate study, blood levels of carboxyhaemoglobin being correlated with the reported tobacco consumption. The correlation was good and ex-smokers had blood levels in the normal range (C Wilhelmsson, unpublished observations).
The completeness and quality of endpoints (death and non-fatal reinfarction) have been tested and discussed previously,8"1I as have the methods used during the follow-up period.9 The two groups studied were comparable regarding variables recorded before the infarction except for a slight but not significant difference in the frequency of hypertension before myocardial infarction. When other variables of more pronounced prognostic importance after myocardial infarction were analysed the prognostic index was worse in the group who stopped smoking and this group had a slightly higher predicted two year mortality than the group that continued to smoke. Thus, the patients who stopped smoking had a more severe risk of myocardial infarction. The survival rate in this group was, however, considerably higher, reflecting an inversion of the expected prognosis. The difference in group survival rate was shown in the totality of patients as well as among men under 50 years of age, and in the former the lack of difference between the two groups in mortality after one year supports an early effect of the cessation of smoking, since a higher mortality was predicted among those who stopped. '4 In the lower age groups the difference was evident within three years after the myocardial infarction. This rapid beneficial effect of withdrawal from cigarette smoking suggests improvement of factors with relatively short time constants, such as a decrease in lethal arrhythmias, or a change of platelet adhesiveness or of myocardial metabolism, rather than effects mediated via progressive changes in the coronary arteries.
The observed reduction of mortality was supported by our previous finding4 and by other investigators.5-717 The findings were further supported by the observed reduction of non-fatal reinfarctions.
The present study shows a reversion of the expected prognosis after myocardial infarction caused by changing the smoking habit. Tobacco smoking is a major risk factor both for the initial occurrence of clinical coronary heart disease and for the prediction of subsequent episodes. The finding of this study suggests that it is highly plausible that tobacco smoking among survivors of myocardial infarction makes a causal contribution to reinfarction and coronary death. 
